We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a user's pocket. The t:flex Insulin Delivery System is used by customers with g... Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a user's pocket. The t:flex Insulin Delivery System is used by customers with greater insulin needs. The t:slim G4 Insulin Delivery system is a continuous glucose monitoring enabled pump with a touch screen. Tandem Diabetes also sells pump-related supplies and accessories. Pump sales contribute the majority of revenue. The firm generates virtually all of its revenue in the United States. Show more
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2024 and increased sales...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on...
DURHAM, N.C., March 18, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the worldβs largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $275.0 million aggregate principal amount of 1.50% Convertible...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions and other factors...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.17 | 9.65277777778 | 43.2 | 47.44 | 41.8 | 1416220 | 43.64227807 | CS |
4 | 14.38 | 43.5889663534 | 32.99 | 47.44 | 30.12 | 1678240 | 39.30065602 | CS |
12 | 24.235 | 104.75470067 | 23.135 | 47.44 | 22.03 | 1958041 | 32.60770873 | CS |
26 | 29.46 | 164.489112228 | 17.91 | 47.44 | 17.33 | 1675550 | 29.02533391 | CS |
52 | 14.21 | 42.8528347407 | 33.16 | 47.44 | 13.82 | 1590672 | 26.69825275 | CS |
156 | -30.97 | -39.5328057187 | 78.34 | 155.86 | 13.82 | 1126094 | 50.12739353 | CS |
260 | -17.78 | -27.2908672295 | 65.15 | 155.86 | 13.82 | 1122436 | 61.15142816 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions